“By centering preeclampsia survivors as experts and co-authors, alongside clinicians, researchers, and payers, we have produced a practical and proactive comprehensive Care Plan. It is written in clear and simple language, can be easily incorporated into electronic health record (EHR) systems, and is designed to be a cooperative plan for both women and their care teams. With consistent implementation in any setting, we expect this Care Plan will help address inequalities in maternal care.”
Eleni Tsigas, CEO of the Preeclampsia Foundation and one of the co-authors
“This new comprehensive Care Plan, developed by a diverse group of preeclampsia experts, payers, and advocates is a specific and clear set of recommendations based on peer-reviewed evidence and expert opinion.”
James Roberts, M.D., a Maternal-Fetal Medicine researcher at the Magee-Womens Research Institute, UPMC and founding Principal Investigator of the Global Pregnancy Collaboration and one of the lead authors.
Study analyzed RNA in 2,539 blood samples from 1,840 women in the United States, Europe and Africa.
Study with leading physician-scientists will provide unprecedented insights into the underlying biology of pregnancy to identify those most at risk for adverse pregnancy complications that affect 1 in 5 pregnancies.
Study shows 91% of the study participants desired predictive testing for preeclampsia and 88% reported they would be more motivated to follow their provider’s medication recommendations if at high risk.
Study analyzed RNA in 2,539 blood samples from 1,840 women in the United States, Europe and Africa.
Study with leading physician-scientists will provide unprecedented insights into the underlying biology of pregnancy to identify those most at risk for adverse pregnancy complications that affect 1 in 5 pregnancies.
Study shows 91% of the study participants desired predictive testing for preeclampsia and 88% reported they would be more motivated to follow their provider’s medication recommendations if at high risk.
